Latest news

8th October 2018

MetaboGen reaches development goal – first product ready for safety study

BioGaia today announced that its´ subsidiary MetaboGen has reached an important development goal. The first version of its next generati (...) Read the full story

Contact us

MetaboGen AB

MetaboGen AB
P.O. Box 3242
103 64 Stockholm
Sweden

Visiting Address

AZ BioVentureHub, HE424
c/o AstraZeneca R&D Mölndal
431 83 Mölndal

Name *
Company *
E-mail *
Phone
Message *
Fields marked with * are mandatory.

Latest news

8th October 2018

MetaboGen reaches development goal – first product ready for safety study

BioGaia today announced that its´ subsidiary MetaboGen has reached an important development goal. The first version of its next generati (...) Read the full story

  • Metabogen
    Technology

    MetaboGen has built a platform that integrates top-of-the line metagenomic data analysis with strain identification and subsequent development as well as clinical programs, to ensure successful development of novel assets.

  • Pharmaceutical
    Industry

    By using our platform, we provide great opportunities for integrating metagenomic analysis into translational parts of pharmaceutical development.

  • Next Generation
    Probiotics

    Thorough investigation of the microbiome and identification of bacterial strains provides the probiotic industry with new tools for more precise product development.